U Square Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.87 Cr
as on 09-12-2024
- Satisfied Charges ₹ 1.34 Cr
as on 09-12-2024
- Revenue -20.30%
(FY 2023)
- Profit -76.24%
(FY 2023)
- Ebitda -174.05%
(FY 2023)
- Net Worth 2.65%
(FY 2023)
- Total Assets 12.39%
(FY 2023)
About U Square Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.87 Cr. The company has closed loans amounting to ₹1.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Kumar and Annapurna Kumar serve as directors at the Company.
- CIN/LLPIN
U24232GJ2007PTC050857
- Company No.
050857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does U Square Lifescience Private Limited offer?
U Square Lifescience Private Limited offers a wide range of products and services, including Third Party Manufacturing Consultancy, Contract Manufacturing Services, Data Entry & Data Processing Service, Data Collection Services, Packaging Solutions, Package Designing Services.
Who are the key members and board of directors at U Square Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Kumar  | Director | 17-May-2007 | Current |
| Annapurna Kumar | Director | 17-May-2007 | Current |
Financial Performance of U Square Lifescience.
U Square Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.3% decrease. The company also saw a substantial fall in profitability, with a 76.24% decrease in profit. The company's net worth moved up by a moderate rise of 2.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U Square Lifescience?
Unlock access to U Square Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
U Square International LlpActive 4 years 10 monthsRajiv Kumar and Annapurna Kumar are mutual person
- Mirus Pharma Private LimitedActive 15 years 6 months
Rajiv Kumar and Annapurna Kumar are mutual person
- Dorina Pharmaceutical Private LimitedActive 3 years 1 month
Rajiv Kumar and Annapurna Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 Oct 2022 | ₹4.00 M | Open |
Axis Bank Limited Creation Date: 14 Jul 2021 | ₹4.00 M | Open |
Others Creation Date: 29 Mar 2018 | ₹4.26 M | Open |
How Many Employees Work at U Square Lifescience?
U Square Lifescience has a workforce of 19 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U Square Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U Square Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
